Why the study?
Do transcriptomic biomarkers from a single endomyocardial biopsy improve the accurate diagnosis of myocarditis?
Do transcriptomic biomarkers from a single endomyocardial biopsy improve the accurate diagnosis of myocarditis?
Transcriptomic biomarkers from endomyocardial biopsies may improve the diagnostic accuracy for myocarditis and other inflammatory heart diseases.
Answers are grounded in this paper and cite their sources.
May enhance myocarditis detection via endomyocardial biopsy transcriptomics; leaves open prospective validation before clinical adoption.
Together, these findings demonstrate that transcriptomic biomarkers from a single endomyocardial biopsy can improve the clinical detection of patients with inflammatory diseases of the heart. This approach advances the clinical management and treatment of cardiac disorders with highly variable outcome.
No takes yet. Share an insight, caveat, or question.
Heidecker et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: